Vanguard Fiduciary Trust
ANAB icon

Vanguard Fiduciary Trust’s AnaptysBio ANAB Stock Holding History

Vanguard Fiduciary Trust’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.9M Buy
146,724
+11,642
+9% +$706K ﹤0.01% 1820
2026
Q1 		$7.49M Buy
+135,082
New +$7.27M ﹤0.01% 1869

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Vanguard Fiduciary Trust's ANAB Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its AnaptysBio (ANAB) stake by 8.6% in Q2 2026, buying an estimated $706K and bringing the position to 146,724 shares worth $9.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1820.

Vanguard Fiduciary Trust first reported a position in ANAB in Q1 2026 and has held it in 2 quarters since. 212 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Vanguard Fiduciary Trust held 146,724 shares of AnaptysBio worth $9.9M as of Q2 2026.
  • Vanguard Fiduciary Trust bought 11,642 AnaptysBio shares in Q2 2026, an estimated $706K.
  • AnaptysBio made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #1820 holding.
  • Vanguard Fiduciary Trust first reported a position in AnaptysBio in Q1 2026 and has held it in 2 quarters since.
  • 212 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.